These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 91023

  • 1. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ, Taylor RH, Nineham R, Goff DV, Bloom SR, Sarson D, Alberti KG.
    Lancet; 1979 Nov 03; 2(8149):924-7. PubMed ID: 91023
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
    McLoughlin JC, Buchanan KD, Alam MJ.
    Lancet; 1979 Sep 22; 2(8143):603-5. PubMed ID: 90270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia.
    Jenkins DJ, Goff DV, Leeds AR, Alberti KG, Wolever TM, Gassull MA, Hockaday TD.
    Lancet; 1976 Jul 24; 2(7978):172-4. PubMed ID: 73796
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR, Ebert R, Creutzfeldt W.
    Scand J Gastroenterol; 1981 Jul 24; 16(5):629-32. PubMed ID: 7034156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K, Hillebrand I.
    Dtsch Med Wochenschr; 1981 Aug 28; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract] [Full Text] [Related]

  • 14. Guar gum, dietary fiber and diabetes.
    Med Lett Drugs Ther; 1979 Jun 15; 21(12):51-2. PubMed ID: 449840
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP, Keup U, Thomas G, Puls W.
    Metabolism; 1982 Jul 15; 31(7):710-4. PubMed ID: 7045575
    [Abstract] [Full Text] [Related]

  • 16. Guar gum is not a panacea in diabetes management.
    Carroll DG, Dykes V, Hodgson W.
    N Z Med J; 1981 May 13; 93(683):292-4. PubMed ID: 6265843
    [Abstract] [Full Text] [Related]

  • 17. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
    Ruppin H, Hagel J, Feuerbach W, Schutt H, Pichl J, Hillebrand I, Bloom S, Domschke W.
    Gastroenterology; 1988 Jul 13; 95(1):93-9. PubMed ID: 3286363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J, Luyckx AS, Lefebvre PJ.
    Diabetologia; 1981 Nov 13; 21(5):446-51. PubMed ID: 7028558
    [Abstract] [Full Text] [Related]

  • 20. Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses.
    Requejo F, Uttenthal LO, Bloom SR.
    Diabet Med; 1990 Jul 13; 7(6):515-20. PubMed ID: 2163805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.